Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

791 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).
Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. Poynard T, et al. Among authors: trepo c. Lancet. 1998 Oct 31;352(9138):1426-32. doi: 10.1016/s0140-6736(98)07124-4. Lancet. 1998. PMID: 9807989 Clinical Trial.
Fibrinolytic therapy for portal vein thrombosis.
Bizollon T, Bissuel F, Detry L, Trepo C. Bizollon T, et al. Among authors: trepo c. Lancet. 1991 Jun 8;337(8754):1416. doi: 10.1016/0140-6736(91)93101-e. Lancet. 1991. PMID: 1674790 No abstract available.
Influence of delta infection on severity of hepatitis B.
Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, Dentico P, Trepo C, Opolon P, Gimson A, Vergani D, Williams R, Rizzetto M. Smedile A, et al. Among authors: trepo c. Lancet. 1982 Oct 30;2(8305):945-7. doi: 10.1016/s0140-6736(82)90156-8. Lancet. 1982. PMID: 6127458
791 results